On Jan. 23, 2014, the National Institutes of Health (NIH) awarded the Benaroya Research Institute at Virginia Mason (BRI) a 7-year grant to lead the Immune Tolerance Network (ITN).

The award, totaled $27 million annually, and supported efforts to develop, coordinate and implement international clinical trials conducted by the ITN to evaluate novel therapies for transplantation, allergy and autoimmune diseases.